Author:
MEGAHED Safa,HABİB Ahmed,HAMMAD Sherin,KAMAL Amira
Publisher
Turkish Journal of Analytical Chemistry.
Reference16 articles.
1. [1] Elfiky. A., SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective, J. Biomol. Struct. Dyn., 2020 https://doi.org/10.1080/07391102.2020.1761882.
2. [2] Furuta. Y., Komeno. T, Nakamura. T., Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase, Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci. P, 2017. https://doi.org/10.2183/pjab.93.027.
3. [3] Wang. M., Cao R., Zhang. L., Yang. X., Liu.J., Xu. M., Shi. Z., Hu.Z., Zhong. W., Xiao. J. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res., , 2020. https://doi.org/10.1038/s41422-020-0282-0.
4. [4] Cai. Q.,Yang. M., Liu. D., Chen. J., Shu. D., Xia. J., Liao. X., Gu. Y., Cai.Q., Yang. Y., Shen. C., Li. X., Peng, L., Huang, D., Zhang, J., Zhang, S., Wang, F. Liu, J., Chen , L., Chen , S., Wang . Z., Zhang. Z., Cao .R., Zhong. W., Liu. Y. & Liu. L., Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study, Engineering, 2020. https://doi.org/10.1016/j.eng.2020.03.007.
5. [5] Guangling. F., Wenjuan. D., Yuxiao. D., Renyong. Z., Yanyan. G., Chonggang. D.& Jinrui. S. (2015) A kind of Favipiravir has the HPLC assay method of related substance, CN104914185B.